CAYMAN ISLANDS – U.S. and European guidelines start with high-dose second-generation antihistamines, but differ in when to introduce other drugs...
PARIS – Investigational drug ligelizumab achieved a faster response, higher clearance rate in a phase 2b study.
Bedbug exposures in the workplace are on the rise. Dermatologists and other health care professionals can no longer exclusively associate bedbugs...
Bedbugs are an increasing problem in the workplace. Employees must be educated on the signs of a bedbug infestation and take preventive measures...
ORLANDO - Teleconferencing saved money, physician time, and patient exposure to more potent antibiotics.
Perniosis, or chilblain, is characterized by skin lesions that occur as an abnormal reaction to exposure to cold and damp conditions. Ice pack–...
GENEVA – The X-ACT study spotlights profound quality-of-life impairment in patients with chronic spontaneous urticaria.
Gemcitabine-induced pseudocellulitis is a rare cutaneous side effect of gemcitabine therapy. Early recognition of pseudocellulitis may prevent...
GENEVA –Three-quarters of nonresponders to approved dose achieve disease control at 450 mg to 600 mg.
From the Journals
Benefits of the low-histamine diet seen in the study provided enough evidence to recommend that patients with CsU try the diet for several weeks,...